Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
Osteoarthritis
•
Orthopedics
•
Sports Medicine
•
Primary Care
How do you counsel patients with autoimmune disease who are considering platelet-rich plasma injections for a musculoskeletal condition unrelated to their autoimmune disease?
Related Questions
Do you avoid hyaluronic acid injections in patients with chondrocalcinosis on imaging?
Do you prescribe additional exercise for patients who perform manual labor?
What is your approach to work up for patients referred for early onset osteoarthritis?
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?
Would you use febuxostat for an African-American patient with gout and previous cardiovascular events (stroke, MI) who tested positive for HLA-B*5801?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
During treatment of severe osteoporosis, with PTH analogs (abaloparatide or) would rise in alkaline phosphatase level > 200 (in setting of normal GGT) warrant discontinuation of medication?
How do you approach medication management in patients with RA when transitioning from csDMARD triple therapy to anti-TNF?
